IR-Med Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IRME research report →
Companywww.ir-medical.com
IR-Med Inc. , a development stage medical device company, focuses on the development of infra-red light spectroscopy combined with artificial intelligence technology platform to address diagnostic or medical needs. It is developing PressureSafe, a handheld optical monitoring device to support early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear infection (Otitis Media), a common malady in children.
- CEO
- Oded Bashan
- IPO
- 2021
- Employees
- 3
- HQ
- Rosh Pinna, IL
Price Chart
Valuation
- Market Cap
- $540.67K
- P/E
- -0.29
- P/S
- 20.80
- P/B
- -0.83
- EV/EBITDA
- -0.91
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 23.08%
- Op Margin
- -3319.23%
- Net Margin
- -6738.46%
- ROE
- 372.24%
- ROIC
- 230.13%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-1,899,000 · 61.32%
- EPS
- $-0.03 · 61.95%
- Op Income
- $-1,941,000
- FCF YoY
- 57.14%
Performance & Tape
- 52W High
- $0.13
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.02
- Beta
- 0.69
- Avg Volume
- 6
Get TickerSpark's AI analysis on IRME
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our IRME Coverage
We haven't published any research on IRME yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IRME Report →